The appeal of SAA in investigating various inflammatory and infectious diseases, including COVID-19, is due to its ability to rapidly increase its concentration by more than 1000 times during the first 24-36 hours after the onset of tissue injury and subsequent inflammation. Here, SAA2 is linked to COVID-19.